Cargando…
The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma
Background: Pancreatic ductal adenocarcinoma (PDAC) is dominated by an immunosuppressive microenvironment, which makes immune checkpoint blockade (ICB) often non-responsive. Understanding the mechanisms by which PDAC forms an immunosuppressive microenvironment is important for the development of new...
Autores principales: | Liu, Xuefei, Luo, Ziwei, Ren, Xuechen, Chen, Zhihang, Bao, Xiaoqiong, Zheng, Jianghua, Zuo, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787220/ https://www.ncbi.nlm.nih.gov/pubmed/35087839 http://dx.doi.org/10.3389/fcell.2021.821232 |
Ejemplares similares
-
The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
por: Deng, Junyuan, et al.
Publicado: (2022) -
Single-Cell Transcriptome Reveals the Metabolic and Clinical Features of a Highly Malignant Cell Subpopulation in Pancreatic Ductal Adenocarcinoma
por: Fang, Yangyang, et al.
Publicado: (2022) -
Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023) -
Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022) -
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
por: Gündel, Beate, et al.
Publicado: (2021)